Show simple item record

dc.contributor.authorCamins A.
dc.contributor.authorEttcheto M.
dc.contributor.authorBusquets O.
dc.contributor.authorManzine P.R.
dc.contributor.authorCastro-Torres R.D.
dc.contributor.authorBeas-Zarate C.
dc.contributor.authorVerdaguer E.
dc.contributor.authorSureda F.X.
dc.contributor.authorBulló M.
dc.contributor.authorOlloquequi J.
dc.contributor.authorAuladell C.
dc.contributor.authorFolch J.
dc.date.accessioned2020-09-02T22:14:07Z
dc.date.available2020-09-02T22:14:07Z
dc.date.issued2019
dc.identifier10.1080/13543784.2019.1552677
dc.identifier.citation28, 1, 93-97
dc.identifier.issn13543784
dc.identifier.urihttps://hdl.handle.net/20.500.12728/3876
dc.description[No abstract available]
dc.language.isoen
dc.publisherTaylor and Francis Ltd
dc.subjectAlzheimer’s disease
dc.subjectglucagon
dc.subjectglucagon-like peptide
dc.subjectglucose-dependent insulinotropic peptide
dc.subjecttype 2 diabetes
dc.subjectgastric inhibitory polypeptide
dc.subjectglucagon like peptide
dc.subjectglucagon receptor agonist
dc.subjectgastric inhibitory polypeptide receptor
dc.subjectglucagon like peptide 1
dc.subjectglucagon receptor
dc.subjecthormone receptor
dc.subjectAlzheimer disease
dc.subjectArticle
dc.subjecthuman
dc.subjectlate onset disorder
dc.subjectnonhuman
dc.subjectAlzheimer disease
dc.subjectanimal
dc.subjectdrug development
dc.subjectmolecularly targeted therapy
dc.subjectpathophysiology
dc.subjectprocedures
dc.subjectAlzheimer Disease
dc.subjectAnimals
dc.subjectDrug Development
dc.subjectGlucagon-Like Peptide 1
dc.subjectHumans
dc.subjectMolecular Targeted Therapy
dc.subjectReceptors, Gastrointestinal Hormone
dc.subjectReceptors, Glucagon
dc.titleTriple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
dc.typeArticle


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record